NTEC Intec Pharma Ltd.

3.42
-0.22  -6%
Previous Close 3.64
Open 3.65
Price To Book 2.59
Market Cap 113,877,009
Shares 33,297,371
Volume 383,508
Short Ratio
Av. Daily Volume 323,113

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data due July/August 2019.
AP-CDLD
Advanced Parkinson's Disease

Latest News

  1. Horizons ETFs Rebalances Marijuana-Focused ETFs
  2. Intec Pharma Announces Publication of Article Reviewing Accordion Pill's Unique Gastric Retention Platform in Therapeutic Delivery
  3. Here’s What Hedge Funds Think About Intec Pharma Ltd (NTEC)
  4. Top Marijuana Stocks on the NASDAQ
  5. Intec Pharma Announces Results from Earlier Phase 2 Clinical Trial of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients Published in Parkinsonism and Related Disorders
  6. Intec Pharma Announces Results From Pharmacokinetic Study of AP-CD/LD 50/500 mg Dosed Three Times Daily Were Presented at the XXIV World Congress on Parkinson's Disease and Related Disorders
  7. Intec Pharma to Participate at June Investment Conferences
  8. Intec Pharma Granted European Patent
  9. Intec Pharma Announces Research Collaboration Agreement With Merck
  10. Intec Pharma Reports First Quarter 2019 Financial Results and Corporate Update
  11. Intec Pharma's Data from Pharmacokinetic Study of AP-CD/LD 50/500 mg Dosed Three Times Daily Accepted for Presentation at the XXIV World Congress on Parkinson's Disease and Related Disorders
  12. Intec Pharma Reports Last Patient Last Visit in Pivotal Phase 3 Trial of Accordion Pill™ Carbidopa/Levodopa for the Treatment of Advanced Parkinson's Disease Patients
  13. The New Cannabis ETF Is Already Making Additions
  14. Intec Pharma to Participate in the HC Wainwright Global Life Sciences Conference
  15. A Trio of Indirect Cannabis Plays
  16. Intec Pharma Announces Time Change for Presentation at Barclays Global Healthcare Conference
  17. Intec Pharma to Participate at Four Investment Conferences in March
  18. Intec Pharma Reports Fourth Quarter and Year End 2018 Financial Results and Corporate Update
  19. Biotech Stock Roundup: ICPT Strong on NASH Drug Data, Collaborations & More
  20. Intec Pharma Reports Positive Results from Pharmacokinetic Study of Accordion Pill™ Carbidopa/Levodopa 50/500 mg Dosed Three Times Daily